Explain this page
Arphra AIPlain-English read on Datadog, Inc.’s valuationRatios & metrics
Profitability, returns on capital, growth, and credit — all derived from the historical income statement, balance sheet, and cash flow rows in our data warehouse.
Valuation multiples
Price- and EV-based multiples plus shareholder yields. Snapshot at each fiscal year-end from key_metrics (FMP).
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Headline | |||||||||
| Market cap | — | — | — | — | — | — | — | — | — |
| Enterprise value | — | — | — | — | — | — | — | — | — |
| Multiples | |||||||||
| P / E | — | — | — | — | — | — | — | — | — |
| P / B | — | — | — | — | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — |
| EV / Sales | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — |
| Yields | |||||||||
| Earnings yield | — | — | — | — | — | — | — | — | — |
| Free cash flow yield | — | — | — | — | — | — | — | — | — |
| Dividend yield | — | — | — | — | — | — | — | — | — |
Profitability
Margin structure across the last 5 fiscal years
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Margins | |||||||||
| Gross margin | +77.17% | +79.25% | +80.70% | +80.76% | +79.96% | +82.11% | +78.49% | +80.73% | +79.46% |
| Operating margin | -1.86% | -3.50% | -1.57% | +2.02% | -1.29% | -0.29% | -0.28% | -0.28% | -0.29% |
| EBITDA margin | +2.49% | +2.45% | +7.06% | +11.85% | +7.60% | +8.93% | +8.96% | +8.62% | +8.63% |
| EBIT margin | +0.26% | -1.29% | +3.13% | +7.86% | +4.03% | +5.05% | +4.95% | +4.95% | +4.86% |
| Pre-tax margin | -1.79% | -2.27% | +2.83% | +7.60% | +3.71% | +4.67% | +4.59% | +4.64% | +4.85% |
| Net margin | -2.02% | -2.99% | +2.28% | +6.85% | +3.14% | +4.18% | +4.12% | +4.03% | +4.06% |
| Cost structure | |||||||||
| Cost of revenue / sales | +22.83% | +20.75% | +19.30% | +19.24% | +20.04% | +20.00% | +19.18% | +19.80% | +19.99% |
| R&D intensity | +40.80% | +44.91% | +45.22% | +42.94% | +45.18% | +44.15% | +44.56% | +43.38% | +43.33% |
| SG&A intensity | +38.23% | +37.84% | +37.05% | +35.80% | +36.07% | +36.81% | +36.69% | +35.42% | +37.33% |
| Effective tax rate | — | — | +19.37% | +9.90% | +15.18% | +14.75% | +15.01% | +15.42% | +14.02% |
Returns on capital
ROE / ROA / ROC / ROIC over the relevant capital base, plus the 3-step DuPont decomposition of ROE.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Returns | |||||||||
| Return on equity (ROE) | -1.99% | -3.56% | +2.40% | +6.77% | +2.89% | +4.11% | +4.12% | +3.94% | +3.92% |
| Return on assets (ROA) | -0.87% | -1.67% | +1.23% | +3.18% | +1.62% | +2.08% | +2.09% | +2.05% | +2.03% |
| Return on capital (ROC) | -1.04% | -2.61% | -1.14% | +1.19% | -0.84% | -0.19% | -0.18% | -0.19% | -0.19% |
| Return on invested capital (ROIC) | -0.78% | -1.96% | -0.86% | +4.03% | -0.63% | -0.14% | -0.14% | -0.14% | -0.14% |
| Asset turnover | +43.21% | +55.75% | +54.07% | +46.40% | +51.58% | +49.66% | +50.67% | +50.91% | +49.98% |
| DuPont · ROE decomposition | |||||||||
| Net margin | -2.02% | -2.99% | +2.28% | +6.85% | +3.14% | +4.18% | +4.12% | +4.03% | +4.06% |
| Asset turnover (× revenue / assets) | +43.21% | +55.75% | +54.07% | +46.40% | +51.58% | +49.66% | +50.67% | +50.91% | +49.98% |
| Equity multiplier (× assets / equity) | +228.66% | +213.03% | +194.34% | +213.14% | +178.01% | +197.88% | +197.53% | +192.19% | +193.00% |
Activity & efficiency
Turnover ratios and days-outstanding — how efficiently the business converts assets and working capital into sales and cash.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||
| Asset turnover | 0.43 | 0.56 | 0.54 | 0.46 | 0.52 | 0.50 | 0.51 | 0.51 | 0.50 |
| Fixed-asset turnover | 7.54 | 7.87 | 7.13 | 6.72 | 6.20 | — | — | — | — |
| Inventory turnover | — | — | — | — | — | — | — | — | — |
| Receivables turnover | 3.83 | 4.19 | 4.18 | 4.48 | 4.62 | — | — | — | — |
| Payables turnover | 9.29 | 14.81 | 4.68 | 4.79 | 4.62 | — | — | — | — |
| Days outstanding | |||||||||
| Days sales outstanding (DSO) | 95.38 | 87.06 | 87.34 | 81.44 | 78.95 | — | — | — | — |
| Days inventory outstanding (DIO) | — | — | — | — | — | — | — | — | — |
| Days payables outstanding (DPO) | 39.28 | 24.65 | 77.95 | 76.15 | 79.06 | — | — | — | — |
| Cash conversion cycle | 56.10 | 62.41 | 9.39 | 5.29 | -0.11 | — | — | — | — |
Cash flow quality
How well reported earnings translate into operating and free cash flow, plus reinvestment intensity.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Operating CF / Net income | -13.81 | -8.34 | 13.59 | 4.74 | 9.75 | 7.51 | 7.63 | 7.68 | 7.50 |
| FCF / Net income | -12.08 | -7.05 | 13.02 | 4.55 | 9.29 | 7.27 | 7.42 | 7.46 | 7.33 |
| FCF margin | +24.35% | +21.10% | +29.71% | +31.14% | +29.19% | +30.36% | +30.60% | +30.03% | +29.77% |
| OCF margin | +27.85% | +24.98% | +31.01% | +32.43% | +30.64% | +31.37% | +31.42% | +30.91% | +30.47% |
| CapEx / Revenue | +3.50% | +3.87% | +1.30% | +1.29% | +1.45% | +1.38% | +1.38% | +1.31% | +1.37% |
| CapEx / D&A | 1.57 | 1.87 | 0.62 | 0.63 | 0.40 | — | — | — | — |
| Stock-based comp / Revenue | +15.92% | +21.68% | +22.66% | +21.25% | 0.00% | — | — | — | — |
Per-share & shareholder yield
EPS, book value, sales, cash flow and dividends per share — plus payout / retention.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| EPS · diluted | -0.07 | -0.16 | 0.14 | 0.51 | 0.30 | 2.42 | 2.83 | 3.49 | 4.34 |
| EPS · basic | -0.07 | -0.16 | 0.15 | 0.55 | 0.31 | 2.60 | 2.97 | 3.69 | 4.67 |
| Book value / share | 3.37 | 4.47 | 5.78 | 7.57 | 10.27 | 12.20 | 14.32 | 17.86 | 20.90 |
| Tangible BV / share | 2.37 | 3.32 | 4.75 | 6.55 | 8.77 | 12.20 | 14.32 | 17.86 | 20.90 |
| Sales / share | 3.33 | 5.31 | 6.08 | 7.48 | 9.43 | 11.99 | 14.33 | 17.47 | 20.16 |
| Operating CF / share | 0.93 | 1.33 | 1.88 | 2.43 | 2.89 | 3.76 | 4.50 | 5.40 | 6.14 |
| Free cash flow / share | 0.81 | 1.12 | 1.81 | 2.33 | 2.75 | 3.64 | 4.38 | 5.25 | 6.00 |
| Dividends / share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payout ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Retention ratio | +100.00% | +100.00% | +100.00% | +100.00% | +100.00% | +100.00% | +100.00% | +100.00% | +100.00% |
Growth
Year-over-year change for headline P&L lines, plus through-cycle CAGR
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E | 8y CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Top-line | ||||||||||
| Revenue · YoY | — | +62.82% | +27.06% | +26.12% | +27.68% | +26.75% | +20.67% | +22.18% | +13.70% | +27.71% |
| Gross profit · YoY | — | +67.21% | +29.38% | +26.22% | +26.40% | +30.17% | +15.35% | +25.66% | +11.91% | +28.18% |
| Profit | ||||||||||
| Operating income · YoY | — | -206.41% | +42.99% | +262.22% | -181.74% | +71.82% | -16.94% | -24.76% | -15.62% | — |
| EBITDA · YoY | — | +60.74% | +265.50% | +111.70% | -18.04% | +48.93% | +21.06% | +17.50% | +13.81% | +49.21% |
| Net income · YoY | — | -141.79% | +196.83% | +278.33% | -41.36% | +68.50% | +18.99% | +19.38% | +14.69% | — |
| Operating | ||||||||||
| EBIT · YoY | — | -918.82% | +408.97% | +217.13% | -34.56% | +59.00% | +18.07% | +22.37% | +11.58% | +84.55% |
| R&D · YoY | — | +79.23% | +27.93% | +19.77% | +34.33% | +23.86% | +21.78% | +18.96% | +13.56% | +28.68% |
| Per-share | ||||||||||
| EPS · diluted · YoY | — | -138.45% | +187.50% | +264.29% | -41.18% | +708.14% | +16.75% | +23.24% | +24.47% | — |
| EPS · basic · YoY | — | -138.45% | +193.75% | +266.67% | -43.64% | +739.38% | +14.04% | +24.30% | +26.73% | — |
Credit & leverage
Balance-sheet health + interest coverage + liquidity. Coverage ratios use period-end debt and trailing interest expense.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Leverage | |||||||||
| Total debt | $807.75M | $837.52M | $902.34M | $1.84B | $1.54B | $2.21B | $2.68B | $3.23B | $3.79B |
| Net debt | $536.77M | $498.54M | $572M | $595.2M | $1.13B | $1.12B | $1.37B | $1.64B | $2.02B |
| Net debt / EBITDA | 20.99 | 12.13 | 3.81 | 1.87 | 4.35 | 2.89 | 2.92 | 2.98 | 3.22 |
| Debt / equity | 0.78 | 0.59 | 0.45 | 0.68 | 0.41 | 0.50 | 0.51 | 0.49 | 0.50 |
| Debt / assets | +33.93% | +27.87% | +22.92% | +31.84% | +23.11% | +25.29% | +25.95% | +25.71% | +26.00% |
| Equity / assets | +43.73% | +46.94% | +51.46% | +46.92% | +56.18% | +50.54% | +50.63% | +52.03% | +51.81% |
| Coverage | |||||||||
| EBITDA / interest expense | 1.21 | 2.49 | 23.84 | 44.99 | 23.57 | 30.35 | 30.85 | 28.87 | 29.75 |
| Operating income / interest | -0.91 | -3.55 | -5.31 | 7.68 | -4.01 | -0.98 | -0.96 | -0.95 | -1.00 |
| Interest expense | $21.05M | $16.54M | $6.3M | $7.07M | $11.06M | $12.79M | $15.23M | $19.12M | $21.12M |
| Liquidity | |||||||||
| Current ratio | 3.54 | 3.09 | 3.17 | 2.64 | 3.38 | — | — | — | — |
| Quick ratio | 3.45 | 3.01 | 3.08 | 2.57 | 3.28 | — | — | — | — |
| Cash ratio | 0.51 | 0.45 | 0.33 | 0.67 | 0.25 | — | — | — | — |
| Working capital | $1.34B | $1.58B | $2.18B | $3.05B | $3.79B | — | — | — | — |
| Working capital / revenue | +130.47% | +94.59% | +102.20% | +113.57% | +110.61% | — | — | — | — |
Methodology. ROE / ROA / ROC use period-end balance-sheet denominators (no average-of- period smoothing). ROIC = Operating Income × (1 − inferred effective tax rate) over invested capital, with the effective tax inferred from net-to-operating income when both are positive and a 25% default otherwise. Net debt / EBITDA, debt ratios, and interest-coverage ratios are calculated point-in-time at each fiscal year-end. TTM = trailing 4 quarters (income / cash flow summed, balance sheet = most-recent quarterly snapshot). Through-cycle CAGR in the Growth panel uses the geometric mean of first-to-last period growth across the window (positive values only).